Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis
Clinical trial NCT03920293 · COMPLETED
Trial details
- NCT number
- NCT03920293
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-12
- Primary completion
- 2021-05-11
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.